Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
clinical trials
2
×
life sciences
national blog main
new york
new york blog main
new york top stories
acute migrane
akcea therapeutics
anylam pharmaceuticals
bain capital
bausch health
biotech
boston blog main
boston top stories
breast cancer
cardiomyopathy
desmoid tumor
dihydroergotamine
dihydroergotamine mesylate
drugs
generic drug
glaxosmithkline
impel neuropharma
inotersen
medical device
migraine
multiple myeloma
national organization for rare disorders
national top stories
neuropathy
nirogacestat
onpattro
orbimed
patisiran
pfizer
ra capital
raleigh-durham blog main
raleigh-durham top stories
rare disease drugs
san diego blog main
What
drug
2
×
pfizer
2
×
activity
ago
akcea
alnylam
amyloidosis
approved
attr
available
battle
biotech
companies
days
debilitating
disease
dog
fda
firm
genetic
hasn’t
ipo
ipos
leading
line
medicines
migraine
oks
patients
place
prep
rare
satsuma
securing
sets
slowed
spinout
springworks
stopped
summer
Language
unset
Current search:
drug
×
pfizer
×
" clinical trials "
×
@xconomy.com
4 years ago
Pfizer Spinout SpringWorks, Migraine Drug Firm Satsuma Prep IPOs
@xconomy.com
4 years ago
FDA OKs Pfizer Rare Disease Drug, Sets Up Battle With Alnylam, Akcea
